AstraZeneca accelerates testing of COVID-19 antibody treatments

0
19
AstraZeneca said on Tuesday it expects to move two COVID-19 antibody therapies it has licensed from U.S. researchers into clinical studies in the next two months as the drugmaker ramps up efforts to help combat the health crisis.

Go to Source
Author: